ARTRITE IDIOPATICA GIOVANILE
Angeles-Han ST et al.
Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans for Juvenile Idiopathic Arthritis-Associated and Idiopathic Chronic Anterior Uveitis.
Arthritis Care Res (Hoboken). 2019 September, 2026
ARTRITE IDIOPATICA GIOVANILE
Fautrel B, Mitrovic S, De Matteis A, et al.
EULAR/PReS recommendations for the diagnosis and management of Still’s disease, comprising systemic juvenile idiopathic arthritis and adult-onset Still’s disease
Ann Rheum Dis. Published online October 15, 2024 December, 2024
ARTRITE IDIOPATICA GIOVANILE
G. Ferrara, G. Mastrangelo, P. Barone, F. La Torre, S. Martino, G. Pappagallo, A. Ravelli, A. Taddio, F. Zulian, R. Cimaz, Rheumatology Italian Study Group
Methotrexate in juvenile idiopathic arthritis: advice and recommendations from the MARAJIA expert consensus meeting
Pediatr Rheumatol Online J May, 2022
ARTRITE IDIOPATICA GIOVANILE
Onel KB, Horton DB, Lovell DJ, Shenoi S, Cuello CA, Angeles-Han ST, Becker ML, Cron RQ, Feldman BM, Ferguson PJ, Gewanter H, Guzman J, Kimura Y, Lee T, Murphy K, Nigrovic PA, Ombrello MJ, Rabinovich CE, Tesher M, Twilt M, Klein-Gitelman M, Barbar-Smiley F, Cooper AM, Edelheit B, Gillispie-Taylor M, Hays K, Mannion ML, Peterson R, Flanagan E, Saad N, Sullivan N, Szymanski AM, Trachtman R, Turgunbaev M, Veiga K, Turner AS, Reston JT.
2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic Arthritis
Arthritis Rheumatol April, 2022
ARTRITE IDIOPATICA GIOVANILE
S. Ringold, S T. Angeles-Han, T. Beukelman, D. Lovell, C. A. Cuello, M. L. Becker, R. A. Colbert, B. M. Feldman, P. J. Ferguson, H. Gewanter, J. Guzman, J. Horonjeff, P. A. Nigrovic, M. J. Ombrello, M. H. Passo, M. L. Stoll, C. E. Rabinovich, R. Schneider, O. Halyabar, K. Hays, A. A. Shah, N. Sullivan, A. M. Szymanski, M. Turgunbaev, A. Turner, and J. Reston
2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroiliitis, and Enthesitis
Arthritis Care Res (Hoboken). June, 2019
ARTRITE IDIOPATICA GIOVANILE
S. T. Angeles-Han, S. Ringold, T. Beukelman, D. Lovell, C. A. Cuello, M. L. Becker, R. A. Colbert, B. M. Feldman, G. N. Holland, P. J. Ferguson, H. Gewanter, J. Guzman,11 J. Horonjeff, P. A. Nigrovic, M. J. Ombrello, M. H. Passo, M. L. Stoll, C. E. Rabinovich, H. Nida Sen, R. Schneider, O. Halyabar, K. Hays, A. A. Shah, N. Sullivan, A. M. Szymanski, M. Turgunbaev, A. Turner, and J. Reston
2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis–Associated Uveitis.
Arthritis Care Res (Hoboken). June, 2019
ARTRITE IDIOPATICA GIOVANILE
C. Scott, M. Chan, W. Slamang, L. Okong’o, R. Petty, R. M Laxer, M.-M. Katsicas, F. Fredrick, J. Chipeta, G. Faller, G. Paleggi, C. Saad-Magalhaes, C. Wouters, H. E Foster, R. Kubchandani, N. Ruperto, R. Russo
Juvenile arthritis management in less resourced countries (JAMLess): consensus recommendations from the Cradle of Humankind
Clin Rheumatol May, 2019
ARTRITE IDIOPATICA GIOVANILE
E. M. Morgan, J. E. Munro, J. Horonjeff, B. Horgan, B. Shea, B. M. Feldman, H. Clairman, C. O. Bingham, S. Thornhill, V. Strand, A. Alongi, S. Magni-Manzoni, M. A.J. van Rossum, R. Vesely, J. Vojinovic, H. I. Brunner, J. G. Harris, D. B. Horton, D. J. Lovell, M. Mannion, H. Rahimi, A. Ravelli, S. Ringold, N. Ruperto, M. S. Schrandt, S. Shenoi, N. J. Shiff, K. Toupin-April, N. Tzaribachev, P. Weiss and A. Consolaro
Establishing an Updated Core Domain Set for Studies in Juvenile Idiopathic Arthritis: A Report from the OMERACT 2018 JIA Workshop
The Journal of Rheumatology 2019 May, 2019
ARTRITE IDIOPATICA GIOVANILE
Ravelli A, Consolaro A, Horneff G, Laxer RM, Lovell DJ, Wulffraat NM, Akikusa JD, Al-Mayouf SM, Antón J, Avcin T, Berard RA, Beresford MW, Burgos-Vargas R, Cimaz R, De Benedetti F, Demirkaya E, Foell D, Itoh Y, Lahdenne P, Morgan EM, Quartier P, Ruperto N, Russo R, Saad-Magalhães C, Sawhney S, Scott C, Shenoi S, Swart JF, Uziel Y, Vastert SJ, Smolen JS.
Treating juvenile idiopathic arthritis to target: recommendations of an international task force
Ann Rheum Dis June, 2018
ARTRITE IDIOPATICA GIOVANILE
A. Ravelli, A. Consolaro, G. Horneff, R. M Laxer, D. J Lovell, N. M Wulffraat, J. D Akikusa, S. M. Al-Mayouf, J. Antón, T. Avcin, R. A. Berard, M. W Beresford, R. Burgos-Vargas, R. Cimaz, F. De Benedetti, E. Demirkaya, D. Foell, Y. Itoh, P. Lahdenne, E. M Morgan, P. Quartier, N. Ruperto, R. Russo, C. Saad-Magalhães, S. Sawhney, C. Scott, S. Shenoi, J. F Swart, Y. Uziel, S. J Vastert, J. S Smolen
Treating juvenile idiopathic arthritis to target: recommendations of an international task force
Ann Rheum Dis. May, 2018
ARTRITE IDIOPATICA GIOVANILE
Constantin T, Foeldvari I, Anton J, de Boer J, Czitrom-Guillaume S, Edelsten C, Gepstein R, Heiligenhaus A, Pilkington CA, Simonini G, Uziel Y, Vastert SJ, Wulffraat NM, Haasnoot AM, Walscheid K, Pálinkás A, Pattani R, Györgyi Z, Kozma R, Boom V, Ponyi A, Ravelli A, Ramanan AV.
Consensus-based recommendations for the management of uveitis associated with juvenile idiopathic arthritis: the SHARE initiative
Ann Rheum Dis. May, 2018
ARTRITE IDIOPATICA GIOVANILE
Ravelli A, Minoia F, Davì S, Horne A, Bovis F, Pistorio A, Aricò M, Avcin T, Behrens EM, De Benedetti F, Filipovich L, Grom AA, Henter J, Ilowite NT, Jordan MB, Khubchandani R, Kitoh T, Lehmberg K, Lovell DJ, Miettunen P, Nichols KE, Ozen S, Pachlopnick-Schmid J, Ramanan AV, Russo R, Schneider R, Sterba G, Uziel Y, Wallace C, Wouters C, Wulffraat N, Demirkaya E, Brunner HI, Martini A, Ruperto N, Cron RQ for the Pediatric Rheumatology International Trials Organization (PRINTO); the Childhood Arthritis & Rheumatology Research Alliance (CARRA); the Pediatric Rheumatology Collaborative Study Group (PRCSG); the Histiocyte Society.
2016 Classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative.
Ann Rheum Dis May, 2016
ARTRITE IDIOPATICA GIOVANILE
Ravelli A, Minoia F, Davì S, Horne A, Bovis F, Pistorio A, Aricò M, Avcin T, Behrens EM, De Benedetti F, Filipovic L, Grom AA, Henter JI, Ilowite NT, Jordan MB, Khubchandani R, Kitoh T, Lehmberg K, Lovell DJ, Miettunen P, Nichols KE, Ozen S, Pachlopnik Schmid J, Ramanan AV, Russo R, Schneider R, Sterba G, Uziel Y, Wallace C, Wouters C, Wulffraat N, Demirkaya E, Brunner HI, Martini A, Ruperto N, Cron RQ; Paediatric Rheumatology International Trials Organisation; Childhood Arthritis and Rheumatology Research Alliance; Pediatric Rheumatology Collaborative Study Group; Histiocyte Society.
2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative.
Arthritis Rheumatol March, 2016
MALATTIA DI KAWASAKI
Jone PN et al.
Update on Diagnosis and Management of Kawasaki Disease: A Scientific Statement From the American Heart Association.
Circulation. 2024 September, 2026
MALATTIA DI KAWASAKI
Gorelik M, Chung SA, Ardalan K, Binstadt BA, Friedman K, Hayward K, Imundo LF, Lapidus SK, Kim S, Son MB, Sule S, Tremoulet AH, Van Mater H, Yildirim-Toruner C, Langford CA, Maz M, Abril A, Guyatt G, Archer AM, Conn DL, Full KA, Grayson PC, Ibarra MF, Merkel PA, Rhee RL, Seo P, Stone JH, Sundel RP, Vitobaldi OI, Warner A, Byram K, Dua AB, Husainat N, James KE, Kalot M, Lin YC, Springer JM, Turgunbaev M, Villa-Forte A, Turner AS, Mustafa RA.
2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Kawasaki Disease.
Arthritis Care Res (Hoboken). April, 2022
MALATTIA DI KAWASAKI
Marchesi A, Rigante D, Cimaz R, Ravelli A, Tarissi de Jacobis I, Rimini A, Cardinale F, Cattalini M, De Zorzi A, Dellepiane RM, Salice P, Secinaro A, Taddio A, Palma P, El Hachem M, Cortis E, Maggio MC, Corsello G, Villani A.
Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease.
Ital J Pediatr January, 2021
MALATTIA DI KAWASAKI
De Graeff, N; Groot, N; Ozen, S; Eleftheriou, D; Avcin, T; Bader-Meunier, B; Doležalová, P; Feldman, B; Koné-Paut, I; Lahdenne, P; McCann, L; Pilkington, C; Ravelli, A; van Royen-Kerkhof, A; Uziel, Y; Vastert, S; Wulffraat, N; Kamphuis, S; Brogan, P A; Beresford,MW.
European Consensus-based recommendations for the diagnosis and treatment of Kawasaki disease- the Share initiative.
Rheumatology (Oxford) May, 2019
SCLERODERMIA
Del Galdo F et al
EULAR recommendations for the treatment of systemic sclerosis: 2023 update
Annals of the Rheumatic Diseases 2024 September, 2026
SCLERODERMIA
Smith V, Herrick AL, Ingegnoli F, Damjanov N, De Angelis R, Denton CP, Distler O, Espejo K, Foeldvari I, Frech T, Garro B, Gutierrez M, Gyger G, Hachulla E, Hesselstrand R, Iagnocco A, Kayser C, Melsens K, Müller-Ladner U, Paolino S, Pizzorni C, Radic M, Riccieri V, Snow M, Stevens W, Sulli A, van Laar JM, Vonk MC, Vanhaecke A, Cutolo M
Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud’s phenomenon and systemic sclerosis
EULAR Study Group on Microcirculation in Rheumatic Diseases and the Scleroderma Clinical Trials Consortium Group on Capillaroscopy. Autoimmun Rev. 2020 Mar;19(3):102458. November, 2024
SCLERODERMIA
Foeldvari I, Culpo R, Sperotto F, Anton J, Avcin T, Baildam E, Boros C, Chaitow J, Constantin T, Kasapcopur O, Knupp Feitosa de Oliveira S, Pilkington C, Toplak N, van Royen A, Saad Magalhaes C, Vastert SJ, Wulffraat N, Zulian F.
Consensus-based recommendations for the management of juvenile systemic sclerosis.
Rheumatology (Oxford) April, 2021
SCLERODERMIA
F. Zulian, R. Culpo, F. Sperotto, J. Anton, T. Avcin, E. M Baildam, C. Boros, J. Chaitow, T. Constantin, O. Kasapcopur, S. K. Feitosa de Oliveira, C. A Pilkington, R. Russo, N. Toplak, A. van Royen, C. Saad Magalhães, S. J Vastert, N. M Wulffraat, I. Foeldvari
Consensus-based recommendations for the management of juvenile localised scleroderma.
Ann Rheum Dis May, 2019
LUPUS ERITEMATOSO SISTEMICO
Aringer M.
2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus
Arthritis Rheumatol 2019 September, 2026
LUPUS ERITEMATOSO SISTEMICO
Fanouriakis A et al.
EULAR recommendations for the management of systemic lupus erythematosus with kidney involvement: 2025 update.
Ann Rheum Dis. 2025 September, 2026
LUPUS ERITEMATOSO SISTEMICO
Sammaritano L et al.
American College of Rheumatology (ACR) Guideline for the Treatment of Systemic Lupus Erythematosus.
Arthritis Rheumatol. 2025 September, 2026
LUPUS ERITEMATOSO SISTEMICO
KDIGO 2024 Clinical Practice Guideline for the management of LUPUS NEPHRITIS
Kidney Disease: Improving Global Outcomes (KDIGO) Lupus Nephritis Work Group November, 2024
LUPUS ERITEMATOSO SISTEMICO
Fanouriakis A, Kostopoulou M, Andersen J, Aringer M, Arnaud L, Bae SC, Boletis J, Bruce IN, Cervera R, Doria A, Dörner T, Furie RA, Gladman DD, Houssiau FA, Inês LS, Jayne D, Kouloumas M, Kovács L, Mok CC, Morand EF, Moroni G, Mosca M, Mucke J, Mukhtyar CB, Nagy G, Navarra S, Parodis I, Pego-Reigosa JM, Petri M, Pons-Estel BA, Schneider M, Smolen JS, Svenungsson E, Tanaka Y, Tektonidou MG, Teng YO, Tincani A, Vital EM, van Vollenhoven RF, Wincup C, Bertsias G, Boumpas DT.
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update.
Ann Rheum Dis. 2024 Jan 2;83(1):15-29 November, 2024
LUPUS ERITEMATOSO SISTEMICO
Fanouriakis A, Kostopoulou M, Cheema K, Anders HJ, Aringer M, Bajema I, Boletis J, Frangou E, Houssiau FA, Hollis J, Karras A, Marchiori F, Marks SD, Moroni G, Mosca M, Parodis I, Praga M, Schneider M, Smolen JS, Tesar V, Trachana M, van Vollenhoven RF, Voskuyl AE, Teng YKO, van Leew B, Bertsias G, Jayne D, Boumpas DT.
2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis
Rheum Dis June, 2020
LUPUS ERITEMATOSO SISTEMICO
A. Fanouriakis, M. Kostopoulou, A. Alunno , M. Aringer, I. Bajema, J. N Boletis, R. Cervera, A. Doria, Caroline Gordon, M. Govoni, F. Houssiau, D. Jayne, M. Kouloumas, A. Kuhn, J. L Larsen, K. Lerstrøm, G. Moroni, M. Mosca, M. Schneider, J. S Smolen, E. Svenungsson, V. Tesar, A. Tincani, A. Troldborg, R. van Vollenhoven, J. Wenzel, G. Bertsias, D. T Boumpas
2019 update of the EULAR recommendations for the management of systemic lupus erythematosus
Ann Rheum Dis June, 2019
LUPUS ERITEMATOSO SISTEMICO
N. Groot, N. de Graeff, S. D Marks, P. Brogan, T. Avcin, B. Bader-Meunier, P. Dolezalova, B. M Feldman, I. Kone-Paut, P. Lahdenne, L. McCann, S. Özen, C. A Pilkington, A. Ravelli, A. van Royen-Kerkhof, Y. Uziel, B. J Vastert, N. M Wulffraat, M. W Beresford, S. Kamphuis
European evidence-based recommendations for the diagnosis and treatment of childhood-onset lupus nephritis: the SHARE initiative
Ann Rheum Dis November, 2017
LUPUS ERITEMATOSO SISTEMICO
Groot N, de Graeff N, Avcin T, Bader-Meunier B, Brogan P, Dolezalova P, Feldman B, Kone-Paut I, Lahdenne P, Marks SD, McCann L, Ozen S, Pilkington C, Ravelli A, Royen-Kerkhof AV, Uziel Y, Vastert B, Wulffraat N, Kamphuis S, Beresford MW.
European evidence-based recommendations for diagnosis and treatment of childhood-onset systemic lupus erythematosus: the SHARE initiative.
Ann Rheum Dis November, 2017
LUPUS ERITEMATOSO SISTEMICO
Andreoli L, Bertsias GK, Agmon-Levin N, Brown S, Cervera R, Costedoat-Chalumeau N, Doria A, Fischer-Betz R, Forger F, Moraes-Fontes MF, Khamashta M, King J, Lojacono A, Marchiori F, Meroni PL, Mosca M, Motta M, Ostensen M, Pamfil C, Raio L, Schneider M, Svenungsson E, Tektonidou M, Yavuz S, Boumpas D, Tincani A.
EULAR recommendations for women’s health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome.
Ann Rheum Dis March, 2017
DERMATOMIOSITE GIOVANILE
Ravelli A.
Treating juvenile dermatomyositis to target: Paediatric Rheumatology European Society/Childhood Arthritis and Rheumatology Research Alliance-endorsed recommendations from an international task force.
Ann Rheum Dis. 2025 September, 2026
Lundberg IE, Tjärnlund A, Bottai M, Werth VP, Pilkington C, Visser M, Alfredsson L, Amato AA, Barohn RJ, Liang MH, Singh JA, Aggarwal R, Arnardottir S, Chinoy H, Cooper RG, Dankó K, Dimachkie MM, Feldman BM, Torre IG, Gordon P, Hayashi T, Katz JD, Kohsaka H, Lachenbruch PA, Lang BA, Li Y, Oddis CV, Olesinska M, Reed AM, Rutkowska-Sak L, Sanner H, Selva-O'Callaghan A, Song YW, Vencovsky J, Ytterberg SR, Miller FW, Rider LG;
2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups
International Myositis Classification Criteria Project consortium, The Euromyositis register and The Juvenile Dermatomyositis Cohort Biomarker Study and Repository (JDRG) (UK and Ireland) November, 2024
DERMATOMIOSITE GIOVANILE
Giancane G, Lavarello C, Pistorio A, Oliveira SK, Zulian F, Cuttica R, Fischbach M, Magnusson B, Pastore S, Marini R, Martino S, Pagnier A, Soler C, Staņēvicha V, Ten Cate R, Uziel Y, Vojinovic J, Fueri E, Ravelli A, Martini A, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).
The PRINTO evidence-based proposal for glucocorticoids tapering/discontinuation in new onset juvenile dermatomyositis patients.
Pediatr Rheumatol Online J May, 2019
DERMATOMIOSITE GIOVANILE
Bellutti Enders F, Bader-Meunier B, Baildam E, Constantin T, Dolezalova P, Feldman BM, Lahdenne P, Magnusson B, Nistala K, Ozen S, Pilkington C, Ravelli A, Russo R, Uziel Y, van Brussel M, van der Net J, Vastert S, Wedderburn LR, Wulffraat N, McCann LJ, van Royen-Kerkhof A.
Consensus-based recommendations for the management of juvenile dermatomyositis
Ann Rheum Dis February, 2017
ALTRE VASCULITI
Maz M et al.
2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Giant Cell Arteritis and Takayasu Arteritis.
Arthritis Rheumatol. 2021 Aug;73(8):1349-1365. September, 2026
ALTRE VASCULITI
Chung SA et al.
American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Arthritis Rheumatol. 2021 September, 2026
ALTRE VASCULITI
Hellmich B et al.
EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update.
Ann Rheum Dis. 2024 September, 2026
ALTRE VASCULITI
Dejaco C et al.
EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice: 2023 update.
Ann Rheum Dis. 2024 September, 2026
ALTRE VASCULITI
De Graeff N, Groot N, Brogan P, Ozen S, Avcin T, Bader-Meunier B, Dolezalova P, Feldman BM, Kone-Paut I, Lahdenne P, Marks SD, McCann L, Pilkington C, Ravelli A, van Royen A, Uziel Y, Vastert B, Wulffraat N, Kamphuis S, Beresford MW.
European consensus-based recommendations for the diagnosis and treatment of rare paediatric vasculitides – the SHARE initiative.
Rheumatology (Oxford). May, 2019
ALTRE VASCULITI
Ozen S, Marks SD, Brogan P, Groot N, de Graeff N, Avcin T, Bader-Meunier B, Dolezalova P, Feldman BM, Kone-Paut I, Lahdenne P, McCann L, Pilkington C, Ravelli A, van Royen A, Uziel Y, Vastert B, Wulffraat N, Kamphuis S, Beresford MW
European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative.
Rheumatology (Oxford) March, 2019
ALTRE VASCULITI
Ozen S, Pistorio A, Iusan SM, Bakkaloglu A, Herlin T, Brik R, Buoncompagni A, Lazar C, Bilge I, Uziel Y, Rigante D, Cantarini L, Hilario MO, Silva CA, Alegria M, Norambuena X, Belot A, Berkun Y, Estrella AI, Olivieri AN, Alpigiani MG, Rumba I, Sztajnbok F, Tambic-Bukovac L, Breda L, Al-Mayouf S, Mihaylova D, Chasnyk V, Sengler C, Klein-Gitelman M, Djeddi D, Nuno L, Pruunsild C, Brunner J, Kondi A, Pagava K, Pederzoli S, Martini A, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).
EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria
Ann Rheum Dis May, 2010
ALTRE VASCULITI
Ruperto N, Ozen S, Pistorio A, Dolezalova P, Brogan P, Cabral DA, Cuttica R, Khubchandani R, Lovell DJ, O'Neil KM, Quartier P, Ravelli A, Iusan SM, Filocamo G, Magalhães CS, Unsal E, Oliveira S, Bracaglia C, Bagga A, Stanevicha V, Manzoni SM, Pratsidou P, Lepore L, Espada G, Kone-Paut I, Zulian F, Barone P, Bircan Z, Maldonado Mdel R, Russo R, Vilca I, Tullus K, Cimaz R, Horneff G, Anton J, Garay S, Nielsen S, Barbano G, Martini A; Paediatric Rheumatology International Trials Organisation (PRINTO).
EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part I: Overall methodology and clinical characterisation
Ann Rheum Dis May, 2010
ALTRO
Zhao Y et al.
EULAR/ACR classification criteria for paediatric chronic nonbacterial osteomyelitis (CNO)
Ann Rheum Dis. 2025 September, 2026
ALTRO
Ozen S et al.
EULAR/PReS endorsed recommendations for the management of familial Mediterranean fever (FMF): 2024 update.
Ann Rheum Dis. 2025 September, 2026
ALTRO
Thomas T et al.
Evaluation, Diagnosis, and Treatment of Sydenham Chorea: Consensus Guidelines
Pediatrics 2025 September, 2026
Stuart G. Tangye et Al.
Human Inborn Errors of Immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert Committee
Journal of Clinical Immunology (2022) 42:1473–1507 January, 2024
ALTRO
Henderson LA, Canna SW, Friedman KG, et al.
American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 and Hyperinflammation in Pediatric COVID-19: Version 3
Arthritis Rheumatol. 2022;74(4):e1-e20 January, 2024
ALTRO
M H A Jansen et Al
EULAR/PRES recommendations for vaccination of paediatric patients with autoimmune inflammatory rheumatic diseases: update 2021
Ann Rheum Dis 2023;82:35–47 January, 2024
ALTRO
A R. Bass et Al
2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases
Arthritis Care Res (Hoboken). 2023 March ; 75(3): 449–464 January, 2024
ALTRO
Caorsi R, et AI
Pediatric Recurrent Pericarditis: Appropriateness of the Standard of Care and Response to IL-1 Blockade
J Pediatr. 2023 May;256:18-26.e8 January, 2024
ALTRO
Shakoory B, et al
The 2022 EULAR/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS)
Ann Rheum Dis. 2023 Oct;82(10):1271-1285. December, 2023